EDWARDS LIFESCIENCES CORP
EW · NYSE
Updated at 2026-10-14 08:10:33
- Today's High
- $86.77
- Today’s Low
- $85.07
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $85.24
- Previous Close
- $86.39
- Volume
- 3.32M
- Market Cap
- $49.79B
- P/E Ratio
- 49.06X
- EPS
- $1.72
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- ONE EDWARDS WAY, IRVINE, CA, UNITED STATES, 92614
- Country
- US
- Listing Date
- 2000-03-27
- Fiscal Year End
- December
- Shares Outstanding
- 575.8M
- CIK
- 0001099800
- Website
- www.edwards.com
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring.
Financial Metrics
Revenue
2026-06-30
$1.74B
2026-03-31
$1.64B
2025-12-31
$1.56B
2025-09-30
$1.55B
Operating Expenses
2026-06-30
$830.9M
2026-03-31
$774.6M
2025-12-31
$858.7M
2025-09-30
$784.5M
Net Income
2026-06-30
$241.9M
2026-03-31
$380.7M
2025-12-31
$91.2M
2025-09-30
$291.1M
Net Profit Margin
2026-06-30
13.89%
2026-03-31
23.09%
2025-12-31
5.81%
2025-09-30
18.74%
Earnings Per Share
2026-06-30
$0.78
2026-03-31
$0.78
2025-12-31
$0.58
2025-09-30
$0.67
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$562.2M
2026-03-31
$499.9M
2025-12-31
$133.1M
2025-09-30
$387.6M
Effective Tax Rate
2026-06-30
53.55%
2026-03-31
17.05%
2025-12-31
28.98%
2025-09-30
16.1%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.74B | $1.64B | $1.56B | $1.55B |
| Operating Expenses | $830.9M | $774.6M | $858.7M | $784.5M |
| Net Income | $241.9M | $380.7M | $91.2M | $291.1M |
| Net Profit Margin | 13.89% | 23.09% | 5.81% | 18.74% |
| Earnings Per Share | $0.78 | $0.78 | $0.58 | $0.67 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $562.2M | $499.9M | $133.1M | $387.6M |
| Effective Tax Rate | 53.55% | 17.05% | 28.98% | 16.1% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.